Mostrar el registro sencillo del ítem

dc.contributor.author
Lazic, Milos  
dc.contributor.author
Inzaugarat, Maria Eugenia  
dc.contributor.author
Povero, Davide  
dc.contributor.author
Zhao, Iris C.  
dc.contributor.author
Chen, Mark  
dc.contributor.author
Nalbandian, Madlena  
dc.contributor.author
Miller, Yury I.  
dc.contributor.author
Cherñavsky, Alejandra Claudia  
dc.contributor.author
Feldstein, Ariel E.  
dc.contributor.author
Sears, Dorothy D.  
dc.date.available
2017-06-21T21:55:10Z  
dc.date.issued
2014-09  
dc.identifier.citation
Lazic, Milos; Inzaugarat, Maria Eugenia; Povero, Davide; Zhao, Iris C.; Chen, Mark; et al.; Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis; Public Library of Science; Plos One; 9; 9; 9-2014; 1-11; e107658  
dc.identifier.issn
1932-6203  
dc.identifier.uri
http://hdl.handle.net/11336/18617  
dc.description.abstract
Obesity is associated with metabolic perturbations including liver and adipose tissue inflammation, insulin resistance, and type 2 diabetes. Omega-6 fatty acids (ω6) promote and omega-3 fatty acids (ω3) reduce inflammation as they can be metabolized to pro- and anti-inflammatory eicosanoids, respectively. 12/15-lipoxygenase (12/15-LO) enzymatically produces some of these metabolites and is induced by high fat (HF) diet. We investigated the effects of altering dietary ω6/ω3 ratio and 12/15-LO deficiency on HF diet-induced tissue inflammation and insulin resistance. We examined how these conditions affect circulating concentrations of oxidized metabolites of ω6 arachidonic and linoleic acids and innate and adaptive immune system activity in the liver. For 15 weeks, wild-type (WT) mice were fed either a soybean oil-enriched HF diet with high dietary ω6/ω3 ratio (11∶1, HFH), similar to Western-style diet, or a fat Kcal-matched, fish oil-enriched HF diet with a low dietary ω6/ω3 ratio of 2.7∶1 (HFL). Importantly, the total saturated, monounsaturated and polyunsaturated fat content was matched in the two HF diets, which is unlike most published fish oil studies in mice. Despite modestly increased food intake, WT mice fed HFL were protected from HFH-diet induced steatohepatitis, evidenced by decreased hepatic mRNA expression of pro-inflammatory genes and genes involved in lymphocyte homing, and reduced deposition of hepatic triglyceride. Furthermore, oxidized metabolites of ω6 arachidonic acid were decreased in the plasma of WT HFL compared to WT HFH-fed mice. 12/15-LO knockout (KO) mice were also protected from HFH-induced fatty liver and elevated mRNA markers of inflammation and lymphocyte homing. 12/15-LOKO mice were protected from HFH-induced insulin resistance but reducing dietary ω6/ω3 ratio in WT mice did not ameliorate insulin resistance or adipose tissue inflammation. In conclusion, lowering dietary ω6/ω3 ratio in HF diet significantly reduces steatohepatitis.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Public Library of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Omega 3  
dc.subject
12/15 Lypoxigenase  
dc.subject
Nafld  
dc.subject
Immunity  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-06-21T17:39:26Z  
dc.journal.volume
9  
dc.journal.number
9  
dc.journal.pagination
1-11; e107658  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
San Francisco  
dc.description.fil
Fil: Lazic, Milos. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Inzaugarat, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina  
dc.description.fil
Fil: Povero, Davide. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Zhao, Iris C.. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Chen, Mark. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Nalbandian, Madlena. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Miller, Yury I.. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Cherñavsky, Alejandra Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina  
dc.description.fil
Fil: Feldstein, Ariel E.. University of California at San Diego; Estados Unidos  
dc.description.fil
Fil: Sears, Dorothy D.. University of California at San Diego; Estados Unidos  
dc.journal.title
Plos One  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1371/journal.pone.0107658  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0107658